211 related articles for article (PubMed ID: 20655511)
1. Glycine transporter-1 blockade leads to persistently reduced relapse-like alcohol drinking in rats.
Vengeliene V; Leonardi-Essmann F; Sommer WH; Marston HM; Spanagel R
Biol Psychiatry; 2010 Oct; 68(8):704-11. PubMed ID: 20655511
[TBL] [Abstract][Full Text] [Related]
2. The glycine reuptake inhibitor Org24598 and acamprosate reduce ethanol intake in the rat; tolerance development to acamprosate but not to Org24598.
Lidö HH; Marston H; Ericson M; Söderpalm B
Addict Biol; 2012 Sep; 17(5):897-907. PubMed ID: 21955180
[TBL] [Abstract][Full Text] [Related]
3. Further characterization of the GlyT-1 inhibitor Org25935: anti-alcohol, neurobehavioral, and gene expression effects.
Lidö HH; Jonsson S; Hyytiä P; Ericson M; Söderpalm B
J Neural Transm (Vienna); 2017 May; 124(5):607-619. PubMed ID: 28161754
[TBL] [Abstract][Full Text] [Related]
4. The glycine reuptake inhibitor Org 25935 decreases ethanol intake and preference in male wistar rats.
Molander A; Lidö HH; Löf E; Ericson M; Söderpalm B
Alcohol Alcohol; 2007; 42(1):11-8. PubMed ID: 17098748
[TBL] [Abstract][Full Text] [Related]
5. Influence of age at drinking onset on the alcohol deprivation effect and stress-induced drinking in female rats.
Füllgrabe MW; Vengeliene V; Spanagel R
Pharmacol Biochem Behav; 2007 Feb; 86(2):320-6. PubMed ID: 17098280
[TBL] [Abstract][Full Text] [Related]
6. The dopamine D3 receptor plays an essential role in alcohol-seeking and relapse.
Vengeliene V; Leonardi-Essmann F; Perreau-Lenz S; Gebicke-Haerter P; Drescher K; Gross G; Spanagel R
FASEB J; 2006 Nov; 20(13):2223-33. PubMed ID: 17077299
[TBL] [Abstract][Full Text] [Related]
7. The role of the NMDA receptor in alcohol relapse: a pharmacological mapping study using the alcohol deprivation effect.
Vengeliene V; Bachteler D; Danysz W; Spanagel R
Neuropharmacology; 2005 May; 48(6):822-9. PubMed ID: 15829254
[TBL] [Abstract][Full Text] [Related]
8. Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats.
Heyser CJ; Schulteis G; Durbin P; Koob GF
Neuropsychopharmacology; 1998 Feb; 18(2):125-33. PubMed ID: 9430136
[TBL] [Abstract][Full Text] [Related]
9. Effect of chronic acamprosate treatment on voluntary alcohol intake and beta-endorphin plasma levels in rats selectively bred for high alcohol preference.
Zalewska-Kaszubska J; Górska D; Dyr W; Czarnecka E
Neurosci Lett; 2008 Feb; 431(3):221-5. PubMed ID: 18162308
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of the glycine transporter-1 inhibitor org 25935 for the prevention of relapse in alcohol-dependent patients: a randomized, double-blind, placebo-controlled trial.
de Bejczy A; Nations KR; Szegedi A; Schoemaker J; Ruwe F; Söderpalm B
Alcohol Clin Exp Res; 2014 Sep; 38(9):2427-35. PubMed ID: 25257291
[TBL] [Abstract][Full Text] [Related]
11. Acamprosate: recent findings and future research directions.
Mann K; Kiefer F; Spanagel R; Littleton J
Alcohol Clin Exp Res; 2008 Jul; 32(7):1105-10. PubMed ID: 18540918
[TBL] [Abstract][Full Text] [Related]
12. Schedule-induced alcohol drinking: non-selective effects of acamprosate and naltrexone.
Escher T; Mittleman G
Addict Biol; 2006 Mar; 11(1):55-63. PubMed ID: 16759337
[TBL] [Abstract][Full Text] [Related]
13. The glycine reuptake inhibitor org 25935 interacts with basal and ethanol-induced dopamine release in rat nucleus accumbens.
Lidö HH; Stomberg R; Fagerberg A; Ericson M; Söderpalm B
Alcohol Clin Exp Res; 2009 Jul; 33(7):1151-7. PubMed ID: 19389199
[TBL] [Abstract][Full Text] [Related]
14. The expression of an alcohol deprivation effect in the high-alcohol-drinking replicate rat lines is dependent on repeated deprivations.
Rodd-Henricks ZA; McKinzie DL; Murphy JM; McBride WJ; Lumeng L; Li TK
Alcohol Clin Exp Res; 2000 Jun; 24(6):747-53. PubMed ID: 10888060
[TBL] [Abstract][Full Text] [Related]
15. The metabotropic glutamate 5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine reduces ethanol self-administration in multiple strains of alcohol-preferring rats and regulates olfactory glutamatergic systems.
Cowen MS; Djouma E; Lawrence AJ
J Pharmacol Exp Ther; 2005 Nov; 315(2):590-600. PubMed ID: 16014750
[TBL] [Abstract][Full Text] [Related]
16. The alcohol deprivation effect model for studying relapse behavior: a comparison between rats and mice.
Vengeliene V; Bilbao A; Spanagel R
Alcohol; 2014 May; 48(3):313-20. PubMed ID: 24811155
[TBL] [Abstract][Full Text] [Related]
17. The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption.
Spanagel R; Pendyala G; Abarca C; Zghoul T; Sanchis-Segura C; Magnone MC; Lascorz J; Depner M; Holzberg D; Soyka M; Schreiber S; Matsuda F; Lathrop M; Schumann G; Albrecht U
Nat Med; 2005 Jan; 11(1):35-42. PubMed ID: 15608650
[TBL] [Abstract][Full Text] [Related]
18. Glycine receptors in the nucleus accumbens involved in the ethanol intake-reducing effect of acamprosate.
Chau P; Höifödt-Lidö H; Löf E; Söderpalm B; Ericson M
Alcohol Clin Exp Res; 2010 Jan; 34(1):39-45. PubMed ID: 19860809
[TBL] [Abstract][Full Text] [Related]
19. Effects of treatment with acamprosate on beta-endorphin plasma concentration in humans with high alcohol preference.
Kiefer F; Jahn H; Otte C; Nakovics H; Wiedemann K
Neurosci Lett; 2006 Aug; 404(1-2):103-6. PubMed ID: 16782270
[TBL] [Abstract][Full Text] [Related]
20. The use of a novel drinkometer system for assessing pharmacological treatment effects on ethanol consumption in rats.
Vengeliene V; Noori HR; Spanagel R
Alcohol Clin Exp Res; 2013 Jan; 37 Suppl 1():E322-8. PubMed ID: 22757984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
